## Abstract Inflammatory breast cancer (IBC) accounts for 1% to 5% of all breast cancer cases. Its aggressive biology is characterized by rapid disease progression and poor prognosis. To improve and standardize therapy for IBC, development of novel therapeutics to molecular targets of IBC is key. T
Amphiregulin as a Novel Target for Breast Cancer Therapy
β Scribed by Nicole E. Willmarth; Stephen P. Ethier
- Publisher
- Springer US
- Year
- 2008
- Tongue
- English
- Weight
- 176 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1083-3021
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Although cisplatin plays a vital role in the treatment of several types of human cancer, its wide use is limited by the development of drug resistance and associated toxic side effects. Gold and gold complexes have been used to treat a wide range of ailments for many centuries. In recent years, the
## Abstract It is becoming increasingly clear that angiogenesis plays a crucial role in prostate cancer (CaP) survival, progression, and metastasis. Tumor angiogenesis is a hallmark of advanced cancers and an attractive treatment target in multiple solid tumors. By understanding the molecular basis